beta
ABUS
Arbutus Biopharma Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
Market Cap: 136 Million
Primary Exchange: NASDAQ
Website: http://www.arbutusbio.com
Shares Outstanding: 56.9 Million
Float: 34 Million
Dividend: (%)
Beta: 1.70677464924199
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1464 trading days
From: 2014-03-11 To: 2019-12-12
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|